Frequent NS5A and multiclass resistance in almost all HCV genotypes at DAA failures: What are the chances for second-line regimens?Velia Chiara Di Maio, L. Lambiase, Bianca Bruzzone et al.|Journal of Hepatology|2017Cited by 31
VIRONET-C real life experience of resistance-guided retreatment in HCV infected patients who previously failed a NS5A inhibitor-containing regimenVelia Chiara Di Maio, Sergio Babudieri, M. Aragri et al.|Digestive and Liver Disease|2020Cited by 1
Resistance test guided retreatment of HCV infected patients with a previous failure to a NS5A inhibitor-containing regimen: the Italian Vironet C real life experienceVelia Chiara Di Maio, C. Paternoster, M. Aragri et al.|Digestive and Liver Disease|2019Cited by 0